Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases
Ironwood Pharmaceuticals, a GI-focused healthcare company, and VectivBio Holding AG, a clinical-stage biopharmaceutical company pioneering […]
Sobi to Acquire CTI BioPharma
CTI BioPharma, a commercial biopharmaceutical company focused on the development and commercialization of novel targeted […]
Boston Scientific Closes Acquisition of Apollo Endosurgery
Boston Scientific today announced the close of its acquisition of Apollo Endosurgery, a publicly traded […]
Sumitovant Biopharma Completes Acquisition of Myovant Sciences
Sumitovant Biopharma and Myovant Sciences announced today that Sumitovant has successfully completed its acquisition of […]
Vistagen to Acquire Pherin Pharmaceuticals
Vistagen, a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more